Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: ACC

Proposal to Postpone Dividend Decision


NACKA STRAND, Sweden, March 31, 2020 /PRNewswire/ -- Due to the current uncertainty in global demand caused by the Covid-19 pandemic, the Board of Directors of Hexagon AB has decided to propose a postponement of the decision on the dividend for fiscal year 2019 until the impact of the pandemic is clearer and market conditions have stabilised. The Board's ambition is to fulfil its previously communicated dividend proposal of 0.62 EUR per share at an extraordinary general meeting during the autumn of 2020. Hexagon has a solid financial position, both in terms of capital and liquidity. The Board therefore makes the assessment that the level of the dividend will not risk the company's operations or opportunities for expansion despite the challenging circumstances.

At the same time, the Nomination Committee proposes unchanged Board fees.

Hexagon's Annual General Meeting (AGM) 2020 will be held as planned on April 29. Other proposals are presented in the upcoming notice to the AGM.

This information is information that Hexagon AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 18:00 CET on 31 March 2020.

For further information, please contact:
Maria Luthström, Head of Investor Relations, Hexagon AB, +46-8-601-26-27, [email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/hexagon/r/proposal-to-postpone-dividend-decision,c3078067

The following files are available for download:

https://mb.cision.com/Main/387/3078067/1221929.pdf

Press Release

SOURCE Hexagon


These press releases may also interest you

at 08:45
MastercardBy Vicki HymanPhilanthropist Melinda French Gates, right, spoke with Rosario Dawson, an actor and activist for gender equality, left, and Fatoumata Bâ, center, the founder and executive chair of Janngo Capital, about how to close the...

at 08:45
The Quest Diagnostics Foundation today announced an expanded collaboration with Green Bronx Machine (GBM), a transformational educational nonprofit...

at 08:35
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor...

at 08:25
NOVA LEAP HEALTH CORP. ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has executed a definitive agreement (the "Agreement"), dated April 25, 2024, to acquire a home care services company ("the...

at 08:20
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...

at 08:09
Adyton Resources Corporation announces that it has filed its financial statements for the three and twelve months ended December 31, 2023 and accompanying Management Discussion and Analysis on its SEDAR profile at www.sedar.com. ...



News published on and distributed by: